January 22, 2026
1 min read

Abbott Stock Slumps. The Nutrition Business Is a Drag on Earnings.

Abbott reports fourth-quarter sales that miss analysts’ estimates.

Leave a Reply

Your email address will not be published.

Previous Story

The rise of unproven, potentially dangerous autism treatments

Next Story

Abbott drops as Nutrition unit drives Q4 revenue miss

Previous Story

The rise of unproven, potentially dangerous autism treatments

Next Story

Abbott drops as Nutrition unit drives Q4 revenue miss

Latest from Blog

Go toTop